Fig. 7.
Effect of FCS on migration of Cb2-EGFP–expressing 32D/G-CSF-R cells.
32D/G-CSF-R/Cb2-EGFP cells were exposed to RPMI medium containing or not containing serum during a transwell assay. A quantity of 100 nM of Cb1- or Cb2-specific antagonist was placed in the upper well. The y-axis indicates the percentage of migration from an input of 2 × 105 cells.